Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026
Results from Rhapsido (remibrutinib) pivotal Phase III RemIND trial, the largest study in chronic inducible urticaria, to be…
Roche receives CE mark for new Elecsys NfL blood test to detect neuroinflammation in multiple sclerosis
The Elecsys NfL blood test detects neuroaxonal damage associated with neuroinflammation in adults diagnosed with relapsing remitting multiple…
Glencore Navigates Multiple Challenges as Share Price Holds Strong
Glencore shares hold near highs as the commodities giant manages a strategic pivot after a failed Rio Tinto…
Over 1,000 cyclists ride in Bike MS: Historic New Bern
New Bern, N.C. (WITN) – New Bern hosted their annual historic Bike MS ride on Saturday and Sunday,…